ENTX News and Press, Entera Bio Ltd.

2024-06-20 12:38:50 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips A few penny stocks have already surged recently on the back of an impending meme frenzy. Other penny stocks to buy have remained relatively subdued. It appears to be a prime moment to consi...

2024-06-20 06:47:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are penny stocks to buy that represent purely speculative bets. In a meme frenzy, these stocks can deliver multibagger returns in the blink of an eye. However, some high-risk but ...

2024-06-17 13:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors looking for stocks with millionaire-maker potential must go overweight on growth and penny stocks . When it comes to penny ideas, the thing that comes to mind is speculation or a ...

2024-06-07 07:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips In a meme frenzy, any positive news related to a company has a magnified impact on the stock price. In the euphoria of 2021, companies with ambitious growth plans skyrocketed. The markets didn&...

JERUSALEM, June 03, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today announced Phase 1 clinical data for its hypoparathyroidism focused in...

2024-05-23 06:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Novavax (NASDAQ: NVAX ) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from highs of $320 in 2021 to recent lows o...

JERUSALEM, May 15, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today announced the appointment of Rachel B Wagman, MD, FACE, FACP, as Key ...

JERUSALEM, May 13, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today announced that it has been selected to present data for its investigat...

2024-05-10 16:36:19 ET More on Entera Bio Entera Bio GAAP EPS of -$0.31 beats by $0.01 Seeking Alpha’s Quant Rating on Entera Bio Historical earnings data for Entera Bio Financial information for Entera Bio Read the full article on Seeking Al...

JERUSALEM, May 10, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and small therapeutic proteins, today reported financial results and key business updates for the quarter en...